Trial
NCT04845035
Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
Takeda
Condition
Acute Lymphoblastic Leukemia
Intervention
Dasatinib
Why stopped
The PI plans to revise the study design in a new protocol
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-22